Literature DB >> 25725911

Apollo's curse: neurological causes of motor impairments in musicians.

Eckart Altenmüller1, Christos I Ioannou2, Andre Lee2.   

Abstract

Performing music at a professional level is probably one of the most complex human accomplishments. Extremely fast and complex, temporo-spatially predefined movement patterns have to be learned, memorized, and retrieved with high reliability in order to meet the expectations of listeners. Performing music requires not only the integration of multimodal sensory and motor information, and its precise monitoring via auditory and kinesthetic feedback, but also emotional communicative skills, which provide a "speaking" rendition of a musical masterpiece. To acquire these specialized auditory-sensory-motor and emotional skills, musicians must undergo extensive training periods over many years, which start in early childhood and continue on through stages of increasing physical and strategic complexities. Performance anxiety, linked to high societal pressures such as the fear of failure and heightened self-demands, frequently accompanies these learning processes. Motor disturbances in musicians are common and include mild forms, such as temporary motor fatigue with short-term reduction of motor skills, painful overuse injuries following prolonged practice, anxiety-related motor failures during performances (choking under pressure), as well as more persistent losses of motor control, here termed "dynamic stereotypes" (DSs). Musician's dystonia (MD), which is characterized by the permanent loss of control of highly skilled movements when playing a musical instrument, is the gravest manifestation of dysfunctional motor programs, frequently linked to a genetic susceptibility to develop such motor disturbances. In this review chapter, we focus on different types of motor failures in musicians. We argue that motor failures in musicians develop along a continuum, starting with subtle transient degradations due to fatigue, overuse, or performance stress, which transform by and by into more permanent, still fluctuating motor degradations, the DSs, until a more irreversible condition, MD manifests. We will review the epidemiology and the principles of medical treatment of MD and discuss prevention strategies.
© 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  dynamic stereotype; motor control; musician's dystonia; prevention of dystonia; treatment of dystonia

Mesh:

Year:  2015        PMID: 25725911     DOI: 10.1016/bs.pbr.2014.11.022

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  6 in total

1.  Aberrant cortical excitability reflects the loss of hand dexterity in musician's dystonia.

Authors:  Shinichi Furuya; Kazumasa Uehara; Takashi Sakamoto; Takashi Hanakawa
Journal:  J Physiol       Date:  2018-04-25       Impact factor: 5.182

Review 2.  A unifying motor control framework for task-specific dystonia.

Authors:  Anna Sadnicka; Katja Kornysheva; John C Rothwell; Mark J Edwards
Journal:  Nat Rev Neurol       Date:  2017-11-06       Impact factor: 42.937

3.  Editorial: Music, Brain, and Rehabilitation: Emerging Therapeutic Applications and Potential Neural Mechanisms.

Authors:  Teppo Särkämö; Eckart Altenmüller; Antoni Rodríguez-Fornells; Isabelle Peretz
Journal:  Front Hum Neurosci       Date:  2016-03-09       Impact factor: 3.169

4.  Dystonia.

Authors:  Anna Sadnicka; Anne-Marthe Meppelink; Adam Kalinowski; Pippa Oakeshott; Joost van den Dool
Journal:  BMJ       Date:  2022-04-11

5.  Association of the Yips and Musculoskeletal Problems in Highly Skilled Golfers: A Large Scale Epidemiological Study in Japan.

Authors:  Yasufumi Gon; Daijiro Kabata; Sadahito Kawamura; Masahito Mihara; Ayumi Shintani; Ken Nakata; Hideki Mochizuki
Journal:  Sports (Basel)       Date:  2021-05-21

6.  Surround inhibition can instantly be modulated by changing the attentional focus.

Authors:  Yves-Alain Kuhn; Martin Keller; Benedikt Lauber; Wolfgang Taube
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.